Compare Lupin with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs J.B.CHEMICALS - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN J.B.CHEMICALS LUPIN/
J.B.CHEMICALS
 
P/E (TTM) x 41.5 38.5 107.8% View Chart
P/BV x 3.8 7.2 53.3% View Chart
Dividend Yield % 0.6 0.2 345.7%  

Financials

 LUPIN   J.B.CHEMICALS
EQUITY SHARE DATA
    LUPIN
Mar-20
J.B.CHEMICALS
Mar-18
LUPIN/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs882363 243.0%   
Low Rs505255 198.0%   
Sales per share (Unadj.) Rs339.4169.1 200.7%  
Earnings per share (Unadj.) Rs-5.916.6 -35.8%  
Cash flow per share (Unadj.) Rs15.523.4 66.1%  
Dividends per share (Unadj.) Rs6.002.00 300.0%  
Dividend yield (eoy) %0.90.6 133.7%  
Book value per share (Unadj.) Rs276.7172.5 160.4%  
Shares outstanding (eoy) m453.0083.57 542.1%   
Bonus/Rights/Conversions ESOPBB-  
Price / Sales ratio x2.01.8 111.8%   
Avg P/E ratio x-116.618.6 -626.4%  
P/CF ratio (eoy) x44.813.2 339.7%  
Price / Book Value ratio x2.51.8 139.9%  
Dividend payout %-100.912.0 -837.4%   
Avg Mkt Cap Rs m314,20125,827 1,216.5%   
No. of employees `00018.33.8 485.2%   
Total wages/salary Rs m29,8682,511 1,189.5%   
Avg. sales/employee Rs Th8,400.63,747.4 224.2%   
Avg. wages/employee Rs Th1,632.0665.7 245.2%   
Avg. net profit/employee Rs Th-147.2367.8 -40.0%   
INCOME DATA
Net Sales Rs m153,74814,135 1,087.7%  
Other income Rs m4,838366 1,322.5%   
Total revenues Rs m158,58514,501 1,093.6%   
Gross profit Rs m24,8492,178 1,140.8%  
Depreciation Rs m9,702570 1,703.0%   
Interest Rs m3,63035 10,400.6%   
Profit before tax Rs m16,3551,940 843.2%   
Minority Interest Rs m40-   
Prior Period Items Rs m390-   
Extraordinary Inc (Exp) Rs m-7,5210-   
Tax Rs m11,571552 2,095.1%   
Profit after tax Rs m-2,6941,387 -194.2%  
Gross profit margin %16.215.4 104.9%  
Effective tax rate %70.828.5 248.5%   
Net profit margin %-1.89.8 -17.9%  
BALANCE SHEET DATA
Current assets Rs m154,13210,470 1,472.1%   
Current liabilities Rs m92,2522,749 3,355.8%   
Net working cap to sales %40.254.6 73.7%  
Current ratio x1.73.8 43.9%  
Inventory Days Days8255 148.7%  
Debtors Days Days12978 166.5%  
Net fixed assets Rs m89,0825,811 1,533.0%   
Share capital Rs m906167 542.2%   
"Free" reserves Rs m124,46114,248 873.5%   
Net worth Rs m125,36714,416 869.7%   
Long term debt Rs m17,9330-   
Total assets Rs m249,83917,649 1,415.6%  
Interest coverage x5.556.6 9.7%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.60.8 76.8%   
Return on assets %0.48.1 4.6%  
Return on equity %-2.19.6 -22.3%  
Return on capital %8.713.7 63.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m51,4506,164 834.7%   
Fx outflow Rs m19,4701,334 1,459.1%   
Net fx Rs m31,9804,829 662.2%   
CASH FLOW
From Operations Rs m14,6881,231 1,193.7%  
From Investments Rs m11,070-208 -5,319.5%  
From Financial Activity Rs m-8,906-595 1,496.3%  
Net Cashflow Rs m16,853427 3,945.8%  

Share Holding

Indian Promoters % 46.6 55.4 84.1%  
Foreign collaborators % 0.2 0.3 66.7%  
Indian inst/Mut Fund % 11.3 3.4 333.3%  
FIIs % 31.9 3.9 817.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 37.0 27.3%  
Shareholders   98,259 30,437 322.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   ALEMBIC PHARMA  DISHMAN PHARMA  TTK HEALTHCARE  JUBILANT PHARMOVA   BIOCON   

Compare LUPIN With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

LUPIN 2019-20 Annual Report Analysis (Annual Result Update)

Dec 7, 2020 | Updated on Dec 7, 2020

Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (2QFY21); Net Profit Up 271.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, LUPIN has posted a net profit of Rs 2 bn (up 271.3% YoY). Sales on the other hand came in at Rs 38 bn (down 12.0% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (1QFY21); Net Profit Down 64.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, LUPIN has posted a net profit of Rs 1 bn (down 64.2% YoY). Sales on the other hand came in at Rs 35 bn (down 20.2% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (4QFY20); Net Profit Up 35.5% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, LUPIN has posted a net profit of Rs 4 bn (up 35.5% YoY). Sales on the other hand came in at Rs 38 bn (down 12.7% YoY). Read on for a complete analysis of LUPIN's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On...(Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

Why the Market Fell Yesterday(Fast Profits Daily)

Apr 6, 2021

In this video, I'll tell you the two reasons why the market fell on Monday and how you can prepare yourself for such events in the future.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Apr 16, 2021 (Close)

TRACK LUPIN

COMPARE LUPIN WITH

MARKET STATS